{"GHMDC classification":["Diagnosis"],"GHMDC health topic":["Maternal mortality"],"GHMDC manufacturer coordinates":["37.123225, -78.492772222222"],"GHMDC manufacturer location":["Virginia, United States"],"GHMDC scope":["Clinical trial"],"Page SDG":["SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Momedemameter"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Eclampsia accounts for about 40% of maternal mortality in low resource environments. This condition is characterized by high blood pressure and heightened protein in the urine. Identifying these stages early is essential for successful treatment. However, the tools for detecting blood pressure and analyzing urine are expensive and inaccessible for women in developing countries."],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Momedemameter"],"Page views":[70],"Page year":["Tuesday, 01-Jan-13 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 13:59:08 UTC"]}